Testing effectiveness (Phase 2)UnknownNCT04688983What this trial is testingStudy in Adult Ph-positive ALLWho this might be right forAcute Lymphoblastic Leukemia, Adult Cardiff University 180
Testing effectiveness (Phase 2)Study completedNCT02523976What this trial is testingDasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaWho this might be right forAcute,Leukemia, Lymphoid Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02067143What this trial is testingMRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted MethotrexateWho this might be right forUntreated Philadelphia Positive Acute Lymphoblastic LeukemiaDe NovoSecondary+1 more Gruppo Italiano Malattie EMatologiche dell'Adulto 204
Early research (Phase 1)Study completedNCT00807677What this trial is testingDose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more Millennium Pharmaceuticals, Inc. 31
Not applicableLooking for participantsNCT07433400What this trial is testingLong-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALLWho this might be right forPh Positive ALL Group for Research in Adult Acute Lymphoblastic Leukemia 500
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Not applicableUnknownNCT05024357What this trial is testingTKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALLWho this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaPhiladelphia-Positive Acute Lymphoblastic LeukemiaALL, Adult First Affiliated Hospital Xi'an Jiaotong University 80
Not applicableLooking for participantsNCT07684131What this trial is testingEWALL-PH OBSERVARTORY 2022Who this might be right forAcute Lymphoblastic Leukemia Versailles Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00384228What this trial is testingA Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALLWho this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Looking for participantsNCT03263572What this trial is testingBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaBCR-ABL1 Fusion Protein Expression+5 more M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Early research (Phase 1)Looking for participantsNCT06287528What this trial is testing19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Who this might be right forPhiladelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more Memorial Sloan Kettering Cancer Center 18
Not applicableNo Longer AvailableNCT04559555What this trial is testingMAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia (ALL) Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00244829What this trial is testingImatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Ended earlyNCT05071482What this trial is testingFlumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLWho this might be right forAcute Leukemia Institute of Hematology & Blood Diseases Hospital, China 39
Testing effectiveness (Phase 2)Study completedNCT00529763What this trial is testingDasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) SubjectsWho this might be right forLeukemia Bristol-Myers Squibb 121
Not applicableStudy completedNCT00068523What this trial is testingUltraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT00723203What this trial is testingPanobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaWho this might be right forLeukemia City of Hope Medical Center 16
Not applicableLooking for participantsNCT07493161What this trial is testingChemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALLWho this might be right forPh+ ALL Institute of Hematology & Blood Diseases Hospital, China 110